(Q34583647)

English

Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

author name string

Leandro C A Cerchietti

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Alfredo H Navigante

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Monica A Castro

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Nutrition and Cancer

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

59

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

14-20

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Symptom clusters: the new frontier in symptom management research

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Treatment of symptom clusters: pain, depression, and fatigue

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

A study to assess the existence of the symptom cluster of breathlessness, fatigue and anxiety in patients with advanced lung cancer.

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Systemic inflammation, cachexia and prognosis in patients with cancer.

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Cancer anorexia-cachexia syndrome: cytokines and neuropeptides

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Cytokine-induced sickness behavior.

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Prostaglandin E and prostacyclin receptor expression in tumor and host tissues from MCG 101-bearing mice: a model with prostanoid-related cachexia.

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Inhibitors of COX activity preserve muscle mass in mice bearing the Lewis lung carcinoma, but not the B16 melanoma

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Role of NF-kappaB and cytokine in experimental cancer cachexia

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

The origins of cachexia in acute and chronic inflammatory diseases.

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Eicosanoid-dependent cancer cachexia and wasting

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia.

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Prostaglandins: Their Disappearance from and Release into the Circulation

1 reference

https://api.crossref.org/works/10.1080%2F01635580701365068

21 January 2018

Identifiers

10.1080/01635580701365068

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34583647&oldid=1966798762"